CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
Metformin +1 moredrug
Likely dose
Metformin 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01763346
NCT01763346N/ACompleted
CompareCT.gov

Beta Cell Restoration Through Fat Mitigation

University of Southern California·interventional·Posted Jan 8, 2013·Updated Oct 21, 2019

In Brief

A clinical study evaluating Metformin and gastric banding for Prediabetes and 2 related conditions. Completed, enrolled 88 participants across 1 site.

Detailed Summary

Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrediabetes, Type 2 Diabetes, Obesity
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 8, 2013
Enrollment StartJun 1, 2013
Primary CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 13.5 years ago

Interventions

Metformindrug

metformin 1000 mg bid

gastric bandingdevice

LAP-BAND